Matthew K. Szot - 19 Jan 2023 Form 3 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Chief Financial Officer
Signature
/s/ Matthew Szot
Issuer symbol
CVKD
Transactions as of
19 Jan 2023
Net transactions value
$0
Form type
3
Filing time
19 Jan 2023, 19:26:20 UTC
Previous filing
06 Jul 2022
Next filing
24 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVKD Common Stock 450,000 19 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of restricted common stock, which vest quarterly over a period of two (2) years, subject to certain adjustments.